FANJ
ABMD

Financial Architects (New Jersey)’s Abiomed Inc ABMD Stock Holding History

Financial Architects (New Jersey)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,000
Closed -$1.35M – 1540
2018
Q3 		$1.35M Buy
+3,000
New +$1.18M 0.22% 82
2017
Q3 		– Sell
-2,800
Closed -$401K – 1639
2017
Q2 		$401K Buy
+2,800
New +$376K 0.07% 176

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Financial Architects (New Jersey)'s ABMD Position: Q2 2022 in Review

Financial Architects (New Jersey) sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 800 shares — an estimated $265K sold.

Financial Architects (New Jersey) first reported a position in ABMD in Q2 2013 and held it in 32 quarters. The position peaked at $669K in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Financial Architects (New Jersey) reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 800 Abiomed Inc shares in Q2 2022, an estimated $265K.
  • Financial Architects (New Jersey) first reported a position in Abiomed Inc in Q2 2013 and held it in 32 quarters.
  • Financial Architects (New Jersey)'s Abiomed Inc position peaked at $669K in Q3 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2022, filed 11 Aug 2022.